The gains were on a tight leash as investors tried to cushion their exposure ahead of the corporate results, which serve as a barometer to find out if the recent market rally is in keeping with its fundamentals.
The July-September quarterly results are going to formally kick off with TCS, which is set to announce its numbers on Thursday. Reliance Industries is lined up next.
Driven by pharma, oil and gas and banking stocks, the Sensex ended at 31,924.41, up 77.52 points -- or 0.24 per cent. This is its highest closing since September 21 when it read 32,370.04.
For the 50-share NSE Nifty, the close came in at 10,016.95, higher by 28.20 points, or 0.28 per cent, after shuttling between 10,034 and 10,002.30.
"Main indices traded on a positive note, but investors' cautious view on valuation and upcoming earnings season influenced profit booking on every rise. But mid and small cap attracted investor attention led by ease in GST rates and stock-specific actions while pharma gained after a series of approvals from the USFDA," said Vinod Nair, Head of Research, Geojit Financial Services Ltd.
Domestic financial institutions continued to hold ground and retail investors built up more bets amid a firming Asian trend, said analysts. Domestic institutional investors (DIIs) net picked up shares worth Rs 55.42 crore yesterday. Foreign portfolio investors (FPIs) exited, net pulling out shares amounting to Rs 475.11 crore, showed provisional data.
Key European indices trended down early on.
Drugmaker Lupin topped the Sensex list by surging 1.99 per cent to Rs 1,060.50 after the US Food and Drug Administration approved its generic drug to treat hypertension.
India's second-largest IT firm Infosys went up 1.29 per cent to Rs 935.60 after the company said it has fixed November 1, 2017, as the record date for its share buyback programme.
Other big movers were PowerGrid, Axis Bank, RIL and Coal India.
As for sectoral indices, utilities took the lead, followed by energy.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
